Search Login Register

mafosfamide Summary

115 relevant articles (18 outcomes, 18 trials/studies) found for this Bio-Agent

Description: RN given refers to cis-(+-)-isomer

Also Known As: 2-((2-(bis(2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorin-4-yl)thio)ethanesulfonic acid P-oxide; z 7557; z-7557

Key Diseases for which mafosfamide is Relevant

  1. Leukemia : 8 outcomes 7 studies in 30 results
  2. Acute Myeloid Leukemia (Acute Myelogenous Leukemia) : 7 outcomes 2 studies in 15 results
  3. Neoplasms (Cancer) : 3 outcomes 4 studies in 26 results
  4. Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) : 2 outcomes 1 study in 7 results
  5. BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) : 1 outcome 1 study in 9 results
Show All >>

Drugs Related to mafosfamide

  1. Cyclophosphamide (Cytoxan)
  2. Morphine (MS Contin)
  3. Dexamethasone (Maxidex)
  4. perfosfamide
  5. Asta Z 7557
  6. Etoposide (VP 16)
  7. Ifosfamide
  8. glucosyl-ifosfamide mustard (glufosfamide)
  9. aldophosphamide
  10. Nigericin
Show All >>

Therapies Related to mafosfamide

  1. Bone Marrow Transplantation (Transplantation, Bone Marrow)
  2. Autologous Transplantation (Autograft)
  3. Transplantation (Transplant Recipients)
  4. Drug Therapy (Chemotherapy)
  5. Premedication
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.